Windlas Biotech Limited (NSE:WINDLAS)
India
· Delayed Price · Currency is INR 932.55
+1.90 (0.20%)
Jun 13, 2025, 3:29 PM IST
Windlas Biotech Revenue
In the fiscal year ending March 31, 2025, Windlas Biotech had annual revenue of 7.60B INR with 20.43% growth. Windlas Biotech had revenue of 2.08B in the quarter ending March 31, 2025, with 21.23% growth.
Revenue
7.60B
Revenue Growth
+20.43%
P/S Ratio
2.56
Revenue / Employee
n/a
Employees
1,154
Market Cap
19.49B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 525.78B |
| Divi's Laboratories | 93.60B |
| Cipla | 271.45B |
| Apollo Hospitals Enterprise | 217.94B |
| Mankind Pharma | 122.07B |
| Zydus Lifesciences | 232.42B |
| Aurobindo Pharma | 317.24B |
| Alkem Laboratories | 129.65B |